BioCentury
ARTICLE | Company News

G7 Therapeutics, MorphoSys deal

August 17, 2015 7:00 AM UTC

MorphoSys and G7 partnered exclusively to discover, develop and commercialize antibodies against G protein-coupled receptors. G7 will use its SaBRE and CHESS platforms to generate panels of targets pr...